{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:02:15Z","timestamp":1781629335504,"version":"3.54.5"},"reference-count":82,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>The SARS-CoV-2 pandemic has indeed been one of the most significant problems facing the world in the last decade. It has affected (directly or indirectly) the entire population and all age groups. Children have accounted for 1.7 % to 2 % of the diagnosed cases of COVID-19. COVID-19 in children is usually associated with a mild course of the disease and a better survival rate than in adults. In this review, we investigate the different mechanisms which underlie this observation. Generally, we can say that the innate immune response of children is strong because they have a trained immunity, allowing the early control of infection at the site of entry. Suppressed adaptive immunity and a dysfunctional innate immune response is seen in adult patients with severe infections but not in children. This may relate to immunosenescence in the elderly. Another proposed factor is the different receptors for SARS-CoV-2 and their differences in expression between these age groups. In infants and toddlers, effective immune response to viral particles can be modulated by the pre-existing non-specific effect of live attenuated vaccines on innate immunity and vitamin D prophylaxis. However, all the proposed mechanisms require verification in larger cohorts of patients. Our knowledge about SARS-CoV-2 is still developing.<\/jats:p>","DOI":"10.33549\/physiolres.934759","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T11:00:11Z","timestamp":1639998011000},"page":"S209-S225","source":"Crossref","is-referenced-by-count":14,"title":["COVID-19 and the Differences in Physiological Background Between Children and Adults and Their Clinical Consequences"],"prefix":"10.33549","author":[{"given":"L","family":"KAPUSTOVA","sequence":"first","affiliation":[{"name":"Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"PETROVICOVA","sequence":"additional","affiliation":[{"name":"Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"BANOVCIN","sequence":"additional","affiliation":[{"name":"Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"ANTOSOVA","sequence":"additional","affiliation":[{"name":"University Hospital in Martin, Martin, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"BOBCAKOVA","sequence":"additional","affiliation":[{"name":"Centre for Primary Immunodeficiencies, Clinic of Pneumology and Phthisiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"URBANCIKOVA","sequence":"additional","affiliation":[{"name":"Clinic of Paediatrics, Faculty of Medicine, P.J. Safarik University, Children Faculty Hospital, Kosice, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"RENNEROVA","sequence":"additional","affiliation":[{"name":"Clinic of Paediatric Pulmonology and Phthisiology, Faculty of Medicine, Slovak Medical University, National Institute of Children\u2019s Diseases, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"JESENAK","sequence":"additional","affiliation":[{"name":"Centre for Primary Immunodeficiencies, Clinic of Paediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"AGUAIR JA, TREMBLAY BJ, MANSFIELD MJ, WOODY O, LOBB B, BANERJEE A, CHANDIRAMONAH A, TIESSEN N, CAO Q, DVORKIN-GHEVA A, REVILL S, MILLER MS, CARLSTEN C, ORGAN L, JOSEPH C, JOHN A, HANSON P, AUSTIN RC, MCMANUS BM, JENKINS G, ET AL.: Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. Eur Respir J 56: 2001123, 2020. https:\/\/doi.org\/10.1183\/13993003.01123-2020","DOI":"10.1101\/2020.04.07.030742"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"ARNSON Y, AMITAL H, SHOENFELD Y: Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66: 1137-1142, 2007. https:\/\/doi.org\/10.1136\/ard.2007.069831","DOI":"10.1136\/ard.2007.069831"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"BASTARD P, ROSEN LB, ZHANG Q, HOFFMANN HH, CHBIHI M, LE VOYER T, ROSAIN J, PHILIPPOT Q, SEELEUTHER Y, GERVAIS A, MATERNA M, DE OLIVIERA PMN, MAIA MLS, DINIS ANO BOM AP, AZAMOR T, ARAUJO DA CONCEICAO D, GOUDORIS E, HOMMA A, SLESAK G, SCHAFER J, ET AL.: Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. J Exp Med 218: e20202486. https:\/\/doi.org\/10.1084\/jem.20202486","DOI":"10.1016\/j.tracli.2021.08.075"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"BOBAN M: Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. Int J ClinPract 75: e13868, 2021. https:\/\/doi.org\/10.1111\/ijcp.13868","DOI":"10.1111\/ijcp.13868"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"BOBCAKOVA A, PETRISKOVA J, VYSEHRADSKY R, KOCAN I, KAPUSTOVA L, BARNOVA M, DIAMANT Z, JESENAK M: Immune profile in patients with COVID-19: Lymphocytes exhaustion markers in relationship to clinical outcome. Front Cell Infect Microbiol 11: 646688, 2021. https:\/\/doi.org\/10.3389\/fcimb.2021.646688","DOI":"10.3389\/fcimb.2021.646688"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"BOUILLON R: Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol 13: 466-479, 2017. https:\/\/doi.org\/10.1038\/nrendo.2017.31","DOI":"10.1038\/nrendo.2017.31"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"BUNYAVANICH S, DO A, VICENCIO A: Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323: 2427-2429, 2020. https:\/\/doi.org\/10.1001\/jama.2020.8707","DOI":"10.1001\/jama.2020.8707"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"CASTAGNOLI R, VOTTO M, LICARI A, BRAMBILLA I, BRUNO R, PERLINI S, ROVIDA F, BALDANTI F, MARSEGLIA GL: Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr 174: 882-889, 2020. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.1467","DOI":"10.1001\/jamapediatrics.2020.1467"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"CHAN JF, KOK KH, ZHU Z, CHU H, TO KK, YUAN S, YUEN K: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9: 221-236, 2020. https:\/\/doi.org\/10.1080\/22221751.2020.1719902","DOI":"10.1080\/22221751.2020.1719902"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"CHANNAPPAVANAR R, PERLAM S: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 39: 529\u2010539, 2017. https:\/\/doi.org\/10.1007\/s00281-017-0629-x","DOI":"10.1007\/s00281-017-0629-x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"CHEN R, SANG L, JIANG M, YANG Z, JIA N, FU W, XIE J, GUAN W, LIANG W, NI Z, HU Y, LIU L, SHAN H, LEI C, PENG Y, WEI L, LIU Y, HU Y, PENG P, WANG J, LIU J, CHEN Z, LI G, ZHENG Z, QIU S, LUO J, YE C, ZHU S, ZHENG J, ZHANG N, LI Y, HE J, LI J, LI S, ZHONG N; MEDICAL TREATMENT EXPERT GROUP FOR COVID-19: Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol 146: 89-100, 2020. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.003","DOI":"10.1016\/j.jaci.2020.05.003"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"CHEN Y, GUO Y, PAN Y, ZHAO ZJ: Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun 525: 135-140, 2020. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.071","DOI":"10.1016\/j.bbrc.2020.02.071"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"CHUMAKOV K, BENN CS, AABY P, KOTTILIL S, GALLO R: Can existing live vaccines prevent COVID-19? Science 368: 1187-1188, 2020. https:\/\/doi.org\/10.1126\/science.abc4262","DOI":"10.1126\/science.abc4262"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"DE SMET D, DE SMET K, HERROELEN P, GRYSPEERDT S, MARTENS GA: Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics. (Preprint) medRxiv 2020: 20079376, 2020. https:\/\/doi.org\/10.1101\/2020.05.01.20079376","DOI":"10.1101\/2020.05.01.20079376"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"DIAO B, WANG C, TAN Y, CHEN X, LIU Y, NING L, CHEN L, LIU M, LIU Y, WANG G, YUAN Z, FENG Z, ZHANG Y, WU Y, CHEN Y: Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19). Front Immunol 11: 827, 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.00827","DOI":"10.3389\/fimmu.2020.00827"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"DONG Y, MO X, HU Y, QI X, JIANG F, JIANG Z, TONG S: Epidemiological characteristics of 2143 pediatric patientswith 2019 coronavirus disease in China. Pediatrics 2020. https:\/\/doi.org\/10.1542\/peds.2020-0702","DOI":"10.1542\/peds.2020-0702"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"FRANCESCHI C, GARAGNANI P, PARINI P, GIULIANI C, SANTORO A: Inflammaging: a new immune\u2013metabolic view point for age-related diseases. Nat Rev Endocrinol 14: 576-590, 2018. https:\/\/doi.org\/10.1038\/s41574-018-0059-4","DOI":"10.1038\/s41574-018-0059-4"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"FRANKLIN R, YOUNG A, NEUMANN B, REYAHI A, JOANNIDES A, MODIS Y, FRANKLIN JRM: Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19. medRxiv 2020. https:\/\/doi.org\/10.1101\/2020.04.10.20053207","DOI":"10.1101\/2020.04.10.20053207"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"FELSENSTEIN S, HERBERT JA, MCNAMARA PS, HEDRICH CM: COVID-19: Immunology and treatment options. Clin Immunol 215: 108448, 2020. https:\/\/doi.org\/10.1016\/j.clim.2020.108448","DOI":"10.1016\/j.clim.2020.108448"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"FREEMAN T, SWARTZ T: Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol 11: 1518, 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01518","DOI":"10.3389\/fimmu.2020.01518"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"GALANTI M, SHAMAN J: Direct observation of repeated infections with endemic coronaviruses: J Infect Dis 223: 409-415, 2021. https:\/\/doi.org\/10.1093\/infdis\/jiaa392","DOI":"10.1093\/infdis\/jiaa392"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"GALLO MARIN B, AGHAGOLI G, LAVINE K, YANG L, SIFF EJ, CHIANG SS, SALAZAR-MATHER TP, DUMENCO L, SAVARIA MC, AUNG SN, FLANIGAN T, MICHELOW IC: Predictors of COVID-19 severity: A literature review. Rev Med Virol 31: 1-10, 2021. https:\/\/doi.org\/10.1002\/rmv.2146","DOI":"10.1002\/rmv.2146"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"GATTORNO M, FEDERICI S, PELAGATTI MA, CAORSI R, BRISCA G, MALATTIA C, MARTINI A: Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 28 (Suppl 1): 73-83, 2008. https:\/\/doi.org\/10.1007\/s10875-008-9178-3","DOI":"10.1007\/s10875-008-9178-3"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"GIAMARELLOS-BOURBOULIS EJ, TSILIKA M, MOORLAG S, ANTONAKOS N, KOTSAKI A, DOMINGUEZ-ANDRES J, KYRIAZOPOULOU E, GKAVOGIANNI T, ADAMI ME, DAMORAKI G, KOUFARGYRIS P, KARAGEORGOS A, BOLANOU A, KOENEN H, VAN CREVEL R, DROGGITI DI, RENIERIS G, PAPADOPOULOS A, NETEA MG: Activate: randomized clinical trial of BCG vaccination against infection in the elderly. Cell 183: 315-323, 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.08.051","DOI":"10.1016\/j.cell.2020.08.051"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"HARWEY WT, CARABELLI AM, JACKSON B, GUPTA RK, THOMSON EC, HARRISON EM, LUDDEN C, REEVE R, RAMBAUT A: SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19: 409-424, 2021. https:\/\/doi.org\/10.1038\/s41579-021-00573-0","DOI":"10.1038\/s41579-021-00573-0"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"HENRY BM, LIPPI G, PLEBANI M: Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med 58: 1135\u20101138, 2020. https:\/\/doi.org\/10.1515\/cclm-2020-0272","DOI":"10.1515\/cclm-2020-0272"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, KRUGER N, HERRLER T, ERICHSEN S, SCHIERGENS TS, HERRLER G, WU NH, NITSCHE A, MULLER MA, DROSTEN C, POHLMANN S: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181: 271-280.e8, 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"HOLICK MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007. https:\/\/doi.org\/10.1056\/NEJMra070553","DOI":"10.1056\/nejmra070553"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"HUANG G, KOVALIC A J, GRABER CHJ: Prognostic value of leukocytosis and lymphopenia for severe coronavirus disease. Emerg Infect Dis 26: 1839-1841, 2020. https:\/\/doi.org\/10.3201\/eid2608.201160","DOI":"10.3201\/eid2608.201160"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"IBRAHIM IM, ABDELMALEK DH, ELFIKY AA: GRP78: a cell's response to stress. Life Sci 226: 156-163, 2019. https:\/\/doi.org\/10.1016\/j.lfs.2019.04.022","DOI":"10.1016\/j.lfs.2019.04.022"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"IBRAHIM IM, ABDELMALEK DH, ELSHAHAT ME, ELFIKY AA: COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect 80: 554-562, 2020. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.026","DOI":"10.21203\/rs.2.24599\/v1"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"JESENAK M, BRNDIAROVA M, URBANCIKOVA I, RENNEROVA Z, VOJTKOVA J, BOBCAKOVA A: Immune parameters and COVID-19 infection \u2013 associations with clinical severity and disease prognosis. Front Cell Infect Microbiol 10: 364, 2020. https:\/\/doi.org\/10.3389\/fcimb.2020.00364","DOI":"10.3389\/fcimb.2020.00364"},{"key":"ref32","unstructured":"JESENAK M, RENNEROVA Z, BANOVCIN P: Praktick\u00fd poh\u013ead na v\u00fdvoj imunitn\u00e9ho syst\u00e9mu v detskom veku. Pediatria (Bratisl) 7: 141-149, 2012."},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"JIANG M, GUO I, LUO Q, HUANG Z, ZHAO R, LIU S, LE A, LI J, WAN L: T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19. J Infect Dis 222: 198-202, 2020. https:\/\/doi.org\/10.1093\/infdis\/jiaa252","DOI":"10.1093\/infdis\/jiaa252"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"KINDLER E, THIEL V, WEBER F: Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv Virus Res 96: 219-243, 2016. https:\/\/doi.org\/10.1016\/bs.aivir.2016.08.006","DOI":"10.1016\/bs.aivir.2016.08.006"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"KLEINNIJENHUIS J, VAN CREVEL R, NETEA MG: Trained immunity: consequences for the heterologous effects of BCG vaccination. Trans R Soc Trop Med Hyg 109: 29-35, 2015. https:\/\/doi.org\/10.1093\/trstmh\/tru168","DOI":"10.1093\/trstmh\/tru168"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"KOPECKY-BROMBERG SA, MARTINEZ-SOBRIDO L, FRIEMAN M, BARIC RA, PALESE P: Severe acute respiratory syndrome coronavirus open readingframe (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81: 548-557, 2007. https:\/\/doi.org\/10.1128\/JVI.01782-06","DOI":"10.1128\/jvi.01782-06"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"KUMAR H, KAWAI T, AKIRA S: Pathogen recognition in the innate immune response. Biochem J 420: 1-16, 2009. https:\/\/doi.org\/10.1042\/BJ20090272","DOI":"10.1042\/BJ20090272"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"LEUNG JM, YANG CX, TAM A, SHAIPANICH T, HACKETT TL, SINGHERA GK, DORSCHEID DR, SIN DD: ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J 55: 2000688, 2020. https:\/\/doi.org\/10.1183\/13993003.00688-2020","DOI":"10.1101\/2020.03.18.20038455"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"LOSCOCCO GG: Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19. Int J Hematol 112: 125-126, 2020. https:\/\/doi.org\/10.1007\/s12185-020-02895-w","DOI":"10.1007\/s12185-020-02895-w"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"LU X, PAN J, TAO J, GUO D: SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes 42: 37-45, 2011. https:\/\/doi.org\/10.1007\/s11262-010-0544-x","DOI":"10.1007\/s11262-010-0544-x"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"MAGHBOOLI Z, SAHRAIAN MA, EBRAHIMI M, PAZOKI M, KAFAN S, TABRIZ HM, HADADI A, MONTAZERI M, NASIRI M, SHIRVANI A, HOLICK MF: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng\/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One 15: e023979, 2020. https:\/\/doi.org\/10.1371\/journal.pone.0239799","DOI":"10.1371\/journal.pone.0239799"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"MACHHI J, HERSKOVITZ J, SENAN AM, DUTTA D, NATH B, OLEYNIKOV MD, BLOMBERG WR, MEIGS DD, HASAN M, PATEL M, KLINE P, CHANG RC, CHANG L, GENDELMAN HE, KEVADIYA BD: The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol 15: 359-386, 2020. https:\/\/doi.org\/10.1007\/s11481-020-09944-5","DOI":"10.1007\/s11481-020-09944-5"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"MEHTA P, MCAULEY DF, BROWN M, SANCHEZ E, TATTERSALL RS, MANSON JJ; HLH ACROSS SPECIALITY COLLABORATION, UK: COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395: 1033-1034, 2020. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","DOI":"10.1016\/s0140-6736(20)30628-0"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"MERAD M, MARTIN JC: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20: 355-362, 2020. https:\/\/doi.org\/10.1038\/s41577-020-0331-4","DOI":"10.1038\/s41577-020-0331-4"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"MOORLAG SJCFM, ARTS RJW, VAN CREVEL R, NETEA MG: Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect 25: 1473-1478, 2019. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.020","DOI":"10.1016\/j.cmi.2019.04.020"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"MOSEKILDE L: Vitamin D and the elderly. Clin Endocrinol 62: 265-281, 2005. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02226.x","DOI":"10.1111\/j.1365-2265.2005.02226.x"},{"key":"ref47","unstructured":"MURAMATSU T, MIYAUCHI T: Basigin (CD147): a multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histol Histopathol 18: 981-987, 2003. https:\/\/doi.org\/10.14670\/HH-18.981"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"NETEA MG, DOMINGUEZ-ANDRES J, BARREIRO LB, CHAVAKIS T, DIVANGAHI M, FUCHS E, JOOSTEN LAB, VAM DER MEER JWM, MHLANGA MM, MULDER WJM, RIKSEN NP, SCHLITZER A, SCHULTZE JL, STABELL BENN C, SUN JC, XAVIER RJ, LATZ E: Defining trained immunity and its role in health and disease. Nat Rev Immunol 20: 375-388, 2020. https:\/\/doi.org\/10.1038\/s41577-020-0285-6","DOI":"10.1038\/s41577-020-0285-6"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"O'DRISCOLL M, RIBEIRO DOS SANTOS G, WANG L, CUMMINGS DAT, AZMAN AS, PAIREAU J, FONTANET A, CAUCHEMEZ S, SALJE H: Age-specific mortality and immunity patterns of SARS-CoV-2. Nature 590: 140-145, 2021. https:\/\/doi.org\/10.1038\/s41586-020-2918-0","DOI":"10.1038\/s41586-020-2918-0"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"PANAGIOTOU G, TEE SA, IHSAN Y, ATHAR W, MARCHITELLI G, KELLY D, BOOT CS, STOCK N, MACFARLANE J, MARTINEAU AR, BURNS G, QUINTON R: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol 93: 508511, 2020. https:\/\/doi.org\/10.1111\/cen.14276","DOI":"10.1111\/cen.14276"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"PIERCE CA, PRESTON-HURLBURT P, DAI Y, ASCHNER CB, CHESHENKO N, GALEN B, GARFORTH SJ, HERRERA NG, JANGRA RK, MORANO NC, ORNER E, SY S, CHANDRAN K, DZIURA J, ALMO SC, RING A, KELLER MJ, HEROLD KC, HEROLD BC: Immune responses to SARSCoV-2 infection in hospitalized pediatric and adult patients. Sci Transl Med 12: eabd5487, 2020. https:\/\/doi.org\/10.1126\/scitranslmed.abd5487","DOI":"10.1126\/scitranslmed.abd5487"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"PROMPETCHARA E, KETLOY C, PALAGA T: Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38: 1-9, 2020. https:\/\/doi.org\/10.12932\/AP-200220-0772","DOI":"10.12932\/ap-200220-0772"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"RABI A, AL ZOUBI MS, KASASBEH GA, SALAMEH DM, AL-NASSER AD: SARS-CoV-2 and Coronavirus disease 2019: what we know so far. Pathogens 9: 231, 2020. https:\/\/doi.org\/10.3390\/pathogens9030231","DOI":"10.3390\/pathogens9030231"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"RIBERO SA M, JOUVENET N, DREUX M, NISOLE S: Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog 16: e1008737, 2020. https:\/\/doi.org\/10.1371\/journal.ppat.1008737","DOI":"10.1371\/journal.ppat.1008737"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"RUAN Q, YANG K, WANG W, JIANG L, SONG J: Clinical predictors of mortality due to COVID\u201019 based on ananalysis of data of 150 patients from Wuhan, China. Intensive Care Med 46: 846\u2010848, 2020. https:\/\/doi.org\/10.1007\/s00134-020-05991-x","DOI":"10.1007\/s00134-020-05991-x"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"SALAMANNA F, MAGLIO M, LANDINI MP, FINI M: Body localization of ACE-2: On the trail of the keyhole of SARS-CoV-2. Front Med (Lausanne) 7: 594495, 2020. https:\/\/doi.org\/10.3389\/fmed.2020.594495","DOI":"10.3389\/fmed.2020.594495"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"SHARIFI N, RYAN CJ EDITORIAL: Androgen hazards with COVID-19. Endocr Relat Cancer 27: E1-E3, 2020. https:\/\/doi.org\/10.1530\/ERC-20-0133","DOI":"10.1530\/erc-20-0133"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"SHI CS, NABAR NR, HUANG NN, KEHRL JH: SARS-coronavirus open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov 5: 101, 2019. https:\/\/doi.org\/10.1038\/s41420-019-0181-7","DOI":"10.1038\/s41420-019-0181-7"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"SHOKRI S, MAHMOUNDVAND S, TAHEKRANI R, FARSHADPOUR F: Modulation of the immune response by Middle East respiratory syndrome coronavirus. J Cell Physiol 234: 2143-2151, 2019. https:\/\/doi.org\/10.1002\/jcp.27155","DOI":"10.1002\/jcp.27155"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"SCHNEIDER WM, CHEVILLOTTE M, RICE C: Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32: 513-545, 2014. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120231","DOI":"10.1146\/annurev-immunol-032713-120231"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"SCHULER BA, HABERMANN AC, PLOSA EJ, TAYLOR CJ, JETTER C, KAPP ME, BENJAMIN JT, GULLEMAN P, NICHOLS DS, BRAUNSTEIN LZ, HACKETT A, KOVAL M, GUTTENTAG SH, BLACKWELL TS; VANDERBILT COVID-19 CONSORTIUM COHORT, WEBBER SA, BANOVICH NE, KROPSKI JA, SUCRE JMS; HCA LUNG BIOLOGICAL NETWORK: Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 infection in the lung epithelium. J Clin Invest 131: 2021. https:\/\/doi.org\/10.1101\/2020.05.22.111187","DOI":"10.1101\/2020.05.22.111187"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"SIMON AK, HOLLANDER GA, MCMICHAEL A: Evolution of the immune system in humans from infancy to old age. Proc Biol Sci 282: 20143085, 2015. https:\/\/doi.org\/10.1098\/rspb.2014.3085","DOI":"10.1098\/rspb.2014.3085"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"SINAEI R, PEZESHKI S, PARVARESH S, SINAEI R: Why COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr 17: 10-20, 2021. https:\/\/doi.org\/10.1007\/s12519-020-00392-y","DOI":"10.1007\/s12519-020-00392-y"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"SONG JW, ZHANG C, FAN X, MENG FP, XU Z, XIA P, CAO WJ, YANG T, DAI XP, WANG SY, XU RN, JIANG TJ, LI WG, ZHANG DW, ZHAO P, SHI M, AGRATI C, IPPOLITO G, MAEURER M, ZUMLA A, WANG FS, ZHANG JY: Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun 11: 3410, 2020. https:\/\/doi.org\/10.1038\/s41467-020-17240-2","DOI":"10.1038\/s41467-020-17240-2"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"TAFFAREL P, JORRO BAR\u00d3N F, RODR\u00cdGUEZ AP, WIDMER J, MEREGALLIA C: Multisystem inflammatory syndrome in children related to COVID-19: An update regarding the presentation of two critically ill patients. Arch Argent Pediatr 119: e26-e35, 2021. https:\/\/doi.org\/10.5546\/aap.2021.eng.e26","DOI":"10.5546\/aap.2021.eng.e26"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"TAN L, WANG Q, ZHANG D, DING J, HUANG Q, TANG YQ, WANG Q, MIAO H: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther 5: 33, 2020. https:\/\/doi.org\/10.1038\/s41392-020-0148-4","DOI":"10.1038\/s41392-020-0148-4"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"TERPOS E, NTANASIS-STATHOPOULOS I, ELALAMY I, KASTRITIS E, SERGENTANIS TN, POLITOU M, PSALTOPOULOU T, GEROTZIAFAS G, DIMOPOULOS MA: Hematological findings and complications of COVID-19. Am J Hematol 95: 834-847, 2020. https:\/\/doi.org\/10.1002\/ajh.25829","DOI":"10.1002\/ajh.25829"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"TSABOURI S, MAKIS A, KOSMERI C, SIOMOU E: Risk factors for severity in children with coronavirus disease 2019: A comprehensive literature review. Pediatr Clin North Am 68: 321-338, 2021. https:\/\/doi.org\/10.1016\/j.pcl.2020.07.014","DOI":"10.1016\/j.pcl.2020.07.014"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"WALLS AC, PARK YJ, TORTORICI MA, WALL A, MCGUIRE AT, VEESLER A: Structure, function, and antigenicity of the SARS-CoV-2. Cell 181: 281-292, 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.02.058","DOI":"10.1016\/j.cell.2020.11.032"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"WAMBIER CG, GOREN A, VA\u00d1O-GALV\u00c1N S, RAMOS PM, OSSIMETHA A, NAU G, HERRERA S, MCCOY J: Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res 81: 771-776, 2020. https:\/\/doi.org\/10.1002\/ddr.21688","DOI":"10.1002\/ddr.21688"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"WANG A, CHIOU J, POIRION OB, BUCHANAN J, VALDEZ MJ, VERHEYDEN JM, HOU X, KUDTARKAR P, NARENDRA S, NEWSOME JM, GUO M, FADDAH DA, ZHANG K, YOUNG RE, BARR J, SAJTI E, MISRA R, HUYCK H, ROGERS L, POOLE C, ET AL.: Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes. Elife 9: e62522, 2020. https:\/\/doi.org\/10.7554\/eLife.62522","DOI":"10.7554\/elife.62522.sa2"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"WANG D, HU B, HU C, ZHU F, LIU X, ZHANG J, WANG B, XIANG H, CHENG Z, XIONG Y, ZHAO Y, LI Y, WANG X, PENG Z: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2010infected pneumonia in Wuhan, China. JAMA 323: 1061-1069, 2020. https:\/\/doi.org\/10.1001\/jama.2020.1585","DOI":"10.1001\/jama.2020.1585"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"WANG F, HOU H, LUO Y, TANG G, WU S, HUANG M, LIU W, ZHU Y, LIN Q, MAO L, FANG M, ZHANG H, SUN Z: The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight 5: e137799, 2020. https:\/\/doi.org\/10.1172\/jci.insight.137799","DOI":"10.1172\/jci.insight.137799"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"WANG K, CHEN W, ZHANG Z, YONGQJANG D, JIAN-QI L, PENG D, DING W, YANG Z, XIU-XUAN S, LI G, XU Y, LEI H, LEI Z, ZHIWEI Y, JIE-JIE G, RUO CH, HAI Z, BIN W, YU-MENG Z, GANG N, ET AL.: CD147-spike proteinis a novel route for SARS-CoV-2 infection to host cells. Sig Transduct Target Ther 5: 283, 2020. https:\/\/doi.org\/10.1038\/s41392-020-00426-x","DOI":"10.1038\/s41392-020-00426-x"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"WEISBERG SP, CONNORS TJ, ZHU Y, BALDWIN MR, LIN WH, WONTAKAL S, SZABO PA, WELLS SB, DOGRA P, GRAY J, IDZIKOWSKI E, STELITANO D, BOVIER FT, DAVIS-PORADA J, MATSUMOTO R, POON MML, CHAIT M, MATHIEU C, HORVAT B, DECIMO D, ET AL.: Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol 22: 25-31, 2021. https:\/\/doi.org\/10.1038\/s41590-020-00826-9","DOI":"10.1101\/2020.07.12.20151068"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"XU Z, SHI L, WANG Y, ZHANG J, HUANG L, ZHANG C, LIU S, ZHAO P, LIU H, ZHU L, TAI Y, BAI C, GAO T, SONG J, XIA P, DONG J, ZHAO J, WANG FS: Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8: 420-422, 2020. https:\/\/doi.org\/10.1016\/S2213-2600(20)30076-X","DOI":"10.1016\/s2213-2600(20)30076-x"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"YANG CS, SHIN DM, JO EK: The role of NLR-related protein 3 inflammasome in host defense and inflammatory diseases. Int Neurourol 16: 2-12, 2012. https:\/\/doi.org\/10.5213\/inj.2012.16.1.2","DOI":"10.5213\/inj.2012.16.1.2"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"YGBERG S, NILSSON A: The developing immune system - from foetus to toddler. Acta Paediatr 101: 120-127, 2012. https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02494.x","DOI":"10.1111\/j.1651-2227.2011.02494.x"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"YOSHIKAWA T, HILL TE, YOSHIKAWA N, POPOV VL, GALINDO CL, GARNER HR, PETERS CJ, TSENG CT: Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS One 5: e8729, 2010. https:\/\/doi.org\/10.1371\/journal.pone.0008729","DOI":"10.1371\/journal.pone.0008729"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"ZHOU S, ZHOU H, WALIAN PJ, JAP BK: CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer\u2019s disease amyloid beta-peptide production. Proc Natl Acad Sci U S A 102: 7499-7504, 2005. https:\/\/doi.org\/10.1073\/pnas.0502768102","DOI":"10.1073\/pnas.0502768102"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"ZUO Y, YALAVARTHI S, SHI H, GOCKMAN K, ZUO M, MADISON JA, BLAIR C, WEBER A, BARNES BJ, EGEBLAD M, WOODS RJ, KANTHI Y, KNIGHT JS: Neutrophil extracellular traps in COVID\u201019. JCI Insight 5: e138999, 2020. https:\/\/doi.org\/10.1172\/jci.insight.138999","DOI":"10.1172\/jci.insight.138999"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T11:00:40Z","timestamp":1639998040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2021\/70_S209.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":82,"URL":"https:\/\/doi.org\/10.33549\/physiolres.934759","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,14]]}}}